Expression of interferon alpha/beta receptor in the liver of chronic hepatitis C patients

Journal of Medical Virology

Volumn 56, Issue 3, 1998, Pages 217-223

  Mizukoshi, Eishiro ^a   Kaneko, Shuichi ^a   Yanagi, Masayuki ^a   Ohno, Hideki ^a   Kaji, Kyosuke ^a   Terasaki, Shuichi ^a   Shimoda, Atsushi ^a   Matsushita, Eiki ^a   Kobayashi, Kenichi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

2 5AS; HCV genotype; HCV RNA; IFN receptor; IFN therapy

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; BETA INTERFERON; MESSENGER RNA; VIRUS RNA;

ADULT; ARTICLE; CELL STRAIN HEPG2; CLINICAL ARTICLE; CONTROLLED STUDY; DAUDI CELL; FEMALE; GENE EXPRESSION; HELA CELL; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; MALE; POLYMERASE CHAIN REACTION; RECEPTOR BINDING; RECEPTOR GENE;

ADULT; AGED; ALANINE TRANSAMINASE; BLOTTING, NORTHERN; FEMALE; GENE EXPRESSION; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; INTERFERON-BETA; LIVER; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, INTERFERON; RNA, MESSENGER; RNA, VIRAL;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0031670389     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199811)56:3<217::AID-JMV7>3.0.CO;2-A     Document Type: Article

References (35)

1. Aden DP, Fogel A, Plotkin S, Damjanov I, Knowles BB (1979): Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 282:615-616.
2. Aguet M, Mogensen KE (1983): Interferon receptors. In Gresser I (ed): "Interferon 5." New York: Academic Press, pp 1-22.
3. Cacciarelli TV, Martinez OM, Gish RG, Villanueva JC, Krams SM (1996): Immunoregulatory cytokines in chronic hepatitis C virus infection: Pre-and posttreatment with interferon alfa. Hepatology 24:6-9.
4. Chu CM, Sheen IS, Yeh CT, Hsieh SY, Tsai SL, Liaw YF (1995): Serum levels of interferon-alpha and -gamma in acute and chronic hepatitis B virus infection. Digestive Diseases and Sciences 40: 2107-2112.
5. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ (1994): Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 19:1513-1520.
6. Dukas K, Sarfati P, Vaysse N, Pradayrol L (1993): Quantitation of changes in the expression of multiple genes by simultaneous polymerase chain reaction. Annals of Biochemistry 215:66-72.
7. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, Izumi N, Marumo F, Sato C (1996): Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. New England Journal of Medicine 334:77-81.
8. Foster GR, Ackrill AM, Goldin RD, Kerr IM, Thomas HC, Stark GR (1991): Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA. Proceedings of the National Academy of Sciences U.S.A. 88:2888-2892.
9. Fukuda R, Ishimura N, Kushiyama Y, Moriyama N, Ishihara S, Nagasawa S, Miyake T, Niigaki M, Satoh S, Sakai S, Akagi S, Watanabe M, Fukumoto S (1997): Effectiveness of interferon-alpha therapy in chronic hepatitis C is associated with the amount of interferon-alpha receptor mRNA in the liver. Journal of Hepatology 26:455-461.
10. Gey GO, Coffman WD, Kubicek MT (1952): Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Research :264-265.
11. Hannigan GE, Fish EN, Williams BR (1984): Modulation of human interferon-alpha receptor expression by human interferon-gamma. Journal of Biological Chemistry 259:8084-8086.
12. Ishiyama N, Katayama K, Ishimi N, Takahashi S, Igarashi H, Nakajima H, Saito S, Aoyagi T, Andoh T, Oya A (1993): Quantitative detection of hepatitis C virus RNA by multicyclic RT-PCR. International Hepatology Communications 1:72-79.
13. Jouet P, Roudot Thoraval F, Dhumeaux D, Metreau JM (1994): Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Le Groupe Francais pour l'Etude du Traitement des Hepatites Chroniques NANB/C. Gastroenterology 106:686-690.
14. Kanai K, Kako M, Aikawa T, Kumada T, Kawasaki T, Hatahara T, Oka Y, Mizokami M, Sakai T, Iwata K, Okamoto H, Mayumi M (1995): Clearance of serum hepatitis C virus RNA after interferon therapy in relation to virus genotype. Liver 15:185-188.
15. Kanazawa Y, Hayashi N, Mita E, Li T, Hagiwara H, Kasahara A, Fusamoto H, Kamada T (1994): Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients. Hepatology 20:1121-1130.
16. Kaneko S, Murakami S, Unoura M, Kobayashi K (1992): Quantitation of hepatitis C virus RNA by competitive polymerase chain reaction. Journal of Medical Virology 37:278-282.
17. Lau AS, Hannigen GE, Freedman MH, Williams BR (1986): Regulation of interferon receptor expression in human blood lymphocytes in vitro and during Interferon therapy. Journal of Clinical Investigation 77:1632-1638.
18. Lau JY, Sheron N, Morris AG, Bomford AB, Alexander GJ, Williams R (1991): Interferon-alpha receptor expression and regulation in chronic hepatitis B virus infection. Hepatology 13:332-338.
19. Lau JY, Davis GL, Kniffen J, Qian KP, Urdea MS, Chan CS, Mizokami M, Neuwald PD, Wilber JC (1993): Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 341:1501-1504.
20. Li J, Tripathi BJ, Chalam KV, Tripathi RC (1996): Transforming growth factor-beta 1 and -beta 2 positively regulate TGF-beta 1 mRNA expression in trabecular cells. Investigative Ophthalmology and Visual Science 37:2778-2782.
21. Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J (1982): Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Research 42:3858-3863.
22. Nakajima S, Kuroki T, Shintani M, Kurai O, Takeda T, Nishiguchi S, Shiomi S, Seki S, Kobayashi K (1990): Changes in interferon receptors on peripheral blood mononuclear cells from patients with chronic hepatitis B being treated with interferon. Hepatology 12: 1261-1265.
23. Novick D, Cohen B, Rubinstein M (1994): The human interferon alpha/beta receptor: Characterization and molecular cloning. Cell 77:391-400.
24. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M (1992): Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources. Journal of General Virology 73:673-679.
25. Poynard T, Bedossa P, Chevallier M, Mathurin P, Lemonnier C, Trepo C, Couzigou P, Payen JL, Sajus M, Costa JM, Vidaud M, Chaput JC, Multicenter study group (1995): A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. New England Journal of Medicine 332:1457-1462.
26. Shouval D, Wands JR, Zurawski VR Jr, Isselbacher KJ, Shafritz DA (1982): Selecting binding and complement-mediated lysis of human hepatoma cells (PLC/PRF/5) in culture by monoclonal antibodies to hepatitis B surface antigen. Proceedings of the National Academy of Sciences U.S.A. 79:650-654.
27. Spira J, Povey S, Wiener F, Klein G, Andersson Anvret M (1977): Chromosome banding, isoenzyme studies and determination of Epstein-Barr virus DNA content on human Burkitt lymphoma/ mouse hybrids. International Journal of Cancer 20:849-853.
28. Tanaka E, Kiyosawa K, Matsumoto A, Kashiwakuma T, Hasegawa A, Mori H, Yanagihara O, Ohta Y (1996): Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alfa. Hepatology 23:1330-1333.
29. Tsubota A, Chayama K, Ikeda K, Yasuji A, Koida I, Saitoh S, Hashimoto M, Iwasaki S, Kobayashi M, Hiromitsu K (1994): Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection. Hepatology 19:1088-1094.
30. Uze G, Lutfalla G, Gresser I (1990): Genetic transfer of a functional human interferon alpha receptor into mouse cells: Cloning and expression of its cDNA. Cell 60:225-234.
31. Uze G, Lutfalla G, Mogensen KE (1995): Alpha and beta interferons and their receptor and their friends and relations. Journal of Interferon Cytokine Research 15:3-26.
32. Whitten TM, Quets AT, Schloemer RH (1991): Identification of the hepatitis B virus factor that inhibits expression of the beta interferon gene. Journal of Virology 65:4699-4704.
33. Yatsuhashi H, Yamasaki K, Aritomi T, Maria P, Carmen D, Inoue O, Koga M, Yano M (1997): Quantitative analysis of interferon α/β receptor mRNA in the liver of patients with chronic hepatitis C: Correlation with serum hepatitis C virus-RNA levels and response to treatment with interferon. Journal of Gastroenterological Hepatology 12:460-467.
34. Yoshioka K, Higashi Y, Yamada M, Aiyama T, Takayanagi M, Tanaka K, Okumura A, Iwata K, Kakumu S (1995): Predictive factors in the response to interferon therapy in chronic hepatitis C. Liver 15:57-62.
35. Zoon KC, Arnheiter H (1984): Studies of the interferon receptors. Pharmacological Therapy 24:259-278.